Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E L Matteson

Showing results (81-90 of 88) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 88 results.
Arthritis and Rheumatism|September 1, 1995
Treatment of active refractory rheumatoid arthritis with humanized monoclonal antibody CAMPATH-1H administered by daily subcutaneous injectionE L Matteson, D E Yocum, E W St Clair, et al.
Annals of the Rheumatic Diseases|January 22, 2009
Safety of biological therapies following rituximab treatment in rheumatoid arthritis patientsM C Genovese, F C Breedveld, P Emery, et al.
Annals of the Rheumatic Diseases|July 31, 2008
Comparison of disease activity measures for anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitisP A Merkel, D D Cuthbertson, B Hellmich, et al.
Arthritis and Rheumatism|July 1, 1996
A double-blind, placebo-controlled study of anti-CD5 immunoconjugate in patients with rheumatoid arthritis. The Xoma RA Investigator GroupN J Olsen, R H Brooks, J J Cush, et al.
Arthritis and Rheumatism|October 19, 1999
The Prosorba column for treatment of refractory rheumatoid arthritis: a randomized, double-blind, sham-controlled trialD T Felson, M P LaValley, A R Baldassare, et al.
Gastroenterology|January 1, 1997
A new syndrome of Crohn's disease and pachydermoperiostosis in a familyR F Compton, W J Sandborn, H Yang, et al.
Arthritis and Rheumatism|November 12, 1998
T cell receptor peptide vaccination in rheumatoid arthritis: a placebo-controlled trial using a combination of Vbeta3, Vbeta14, and Vbeta17 peptidesL W Moreland, E E Morgan, T C Adamson, et al.
Arthritis and Rheumatism|October 10, 2012
2012 revised International Chapel Hill Consensus Conference Nomenclature of VasculitidesJ C Jennette, R J Falk, P A Bacon, et al.
Pageof 9

Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
Arthritis and Rheumatism|September 1, 1995
Treatment of active refractory rheumatoid arthritis with humanized monoclonal antibody CAMPATH-1H administered by daily subcutaneous injectionE L Matteson, D E Yocum, E W St Clair, et al.
Annals of the Rheumatic Diseases|January 22, 2009
Safety of biological therapies following rituximab treatment in rheumatoid arthritis patientsM C Genovese, F C Breedveld, P Emery, et al.
Annals of the Rheumatic Diseases|July 31, 2008
Comparison of disease activity measures for anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitisP A Merkel, D D Cuthbertson, B Hellmich, et al.
Arthritis and Rheumatism|July 1, 1996
A double-blind, placebo-controlled study of anti-CD5 immunoconjugate in patients with rheumatoid arthritis. The Xoma RA Investigator GroupN J Olsen, R H Brooks, J J Cush, et al.
Arthritis and Rheumatism|October 19, 1999
The Prosorba column for treatment of refractory rheumatoid arthritis: a randomized, double-blind, sham-controlled trialD T Felson, M P LaValley, A R Baldassare, et al.
Gastroenterology|January 1, 1997
A new syndrome of Crohn's disease and pachydermoperiostosis in a familyR F Compton, W J Sandborn, H Yang, et al.
Arthritis and Rheumatism|November 12, 1998
T cell receptor peptide vaccination in rheumatoid arthritis: a placebo-controlled trial using a combination of Vbeta3, Vbeta14, and Vbeta17 peptidesL W Moreland, E E Morgan, T C Adamson, et al.
Arthritis and Rheumatism|October 10, 2012
2012 revised International Chapel Hill Consensus Conference Nomenclature of VasculitidesJ C Jennette, R J Falk, P A Bacon, et al.
Pageof 9